Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma
- PMID: 9669344
- DOI: 10.1097/00000478-199807000-00004
Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma
Abstract
Vascular endothelial growth factor (VEGF) is a hypoxia-inducible angiogenic factor, which is known to be upregulated in most cases of glioblastoma multiforme (GBM). The expression of VEGF and its receptors in ependymomas, oligodendrogliomas, and particularly the expression during anaplastic progression of these three types of gliomas has not been studied extensively. Fifty-six gliomas, consisting of 10 ependymomas, 12 oligodendrogliomas, 3 anaplastic oligodendrogliomas, 6 astrocytomas grade II, 5 anaplastic astrocytomas, and 20 glioblastoma multiformes, were investigated for VEGF and receptor expression using in situ hybridization (ISH) and reverse transcription polymerase chain reaction (RT-PCR). Results showed that VEGF was moderately to strongly expressed in 8 of 10 ependymomas and in all anaplastic oligodendrogliomas and glioblastoma multiforme cases. These tumors displayed similar degrees of extensive necrosis and vascular proliferation, with VEGF expression consistently seen in tumor cells around necrotic areas. The VEGF expression, although present at a lower level, also was shown in 4 of 12 oligodendrogliomas, in 3 of 6 astrocytomas grade II, and in 2 of 5 anaplastic astrocytomas, with a regional rather than diffuse pattern of positive result. The findings from the in situ hybridization study correlated with the expression index, as determined by reverse transcription polymerase chain reaction. Expression of VEGF was correlated significantly with vascular proliferation (p < 10(-5)) and necrosis (p < 10(-5)), as well as with microvessel density (p = 0.002, rs = 0.41). The VEGF receptors, kinase domain region (KDR) and Fms-like-tyrosine kinase (Flt-1), also were upregulated in the tumor vasculature of glioblastoma multiforme, anaplastic oligodendrogliomas, and ependymomas with necrosis, whereas the astrocytomas grade II, anaplastic astrocytomas, and oligodendroglioma tumors tended to express a weak to nondetectable signal. Anaplastic progression in all three types of gliomas is heralded by the occurrence of small zones of VEGF-expressing cells and early vascular proliferation, followed by an accelerated phase of angiogenesis closely associated with VEGF induction around areas of necrosis and with the expression of VEGF receptors in the tumor vasculature.
Similar articles
-
Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.Cancer Res. 1999 Nov 1;59(21):5608-14. Cancer Res. 1999. PMID: 10554042
-
KDR activation in astrocytic neoplasms.Cancer. 1999 Oct 1;86(7):1335-41. doi: 10.1002/(sici)1097-0142(19991001)86:7<1335::aid-cncr32>3.0.co;2-z. Cancer. 1999. PMID: 10506722
-
Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.Am J Pathol. 1999 Feb;154(2):581-90. doi: 10.1016/S0002-9440(10)65303-5. Am J Pathol. 1999. PMID: 10027415 Free PMC article.
-
Vascular endothelial growth factor and its receptors.Prog Growth Factor Res. 1994;5(1):89-97. doi: 10.1016/0955-2235(94)90019-1. Prog Growth Factor Res. 1994. PMID: 7515293 Review.
-
Vascular endothelial growth factor.Int J Biochem Cell Biol. 1998 Nov;30(11):1169-74. doi: 10.1016/s1357-2725(98)00082-x. Int J Biochem Cell Biol. 1998. PMID: 9839443 Review.
Cited by
-
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma.Neuro Oncol. 2011 Dec;13(12):1331-8. doi: 10.1093/neuonc/nor130. Epub 2011 Sep 6. Neuro Oncol. 2011. PMID: 21896554 Free PMC article. Clinical Trial.
-
Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.Clin Cancer Res. 2008 May 1;14(9):2623-30. doi: 10.1158/1078-0432.CCR-07-4995. Clin Cancer Res. 2008. PMID: 18451225 Free PMC article.
-
A novel tumor-promoting function residing in the 5' non-coding region of vascular endothelial growth factor mRNA.PLoS Med. 2008 May 20;5(5):e94. doi: 10.1371/journal.pmed.0050094. PLoS Med. 2008. PMID: 18494554 Free PMC article.
-
Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma.J Neurooncol. 2010 Jan;96(2):277-85. doi: 10.1007/s11060-009-9961-x. Epub 2009 Jul 19. J Neurooncol. 2010. PMID: 19618120
-
Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.Neuro Oncol. 2016 Feb;18(2):173-83. doi: 10.1093/neuonc/nov288. Epub 2015 Nov 30. Neuro Oncol. 2016. PMID: 26627848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous